Effect of Intraperitoneal Bupivacaine on Postoperative Pain Control in Patients Undergoing Pelvic Organ Prolapse Repair
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 91
- 试验地点
- 1
- 主要终点
- Pain Score at 4 Hours
研究概览
简要总结
The purpose of this study is to evaluate the effects of 30 mL intraperitoneal Bupivacaine without epinephrine 0.25% on postoperative pain control in patients undergoing pelvic organ prolapse repair. The investigators hypothesize that use of intraperitoneal Bupivacaine will decrease postoperative pain scores and opiate consumption in the postoperative period, following pelvic organ prolapse repair.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Intraperitoneal bupivacaine
30 mL of bupivacaine without epinephrine 0.25%
干预措施: Bupivacaine (Drug)
placebo
Saline
干预措施: Saline (Other)
结局指标
主要结局
Pain Score at 4 Hours
时间窗: 4 hours
Patient pain will be measured by means of a numeric rating scale (scale from 0-10 with lower numbers indicating less pain and higher numbers indicating more pain) at 4 hours after surgical pelvic organ prolapse repair
次要结局
- Hospital Length of Stay(Up to 24 hours)
- Total Opiate Consumption(First 24 hours postoperatively)
- Pain Score at 8 Hours, 12 Hours and 24 Hours(8 hours, 12 hours and 24 hours)
- Time to First Narcotic(Up to 24 hours)
研究者
James Ryan Stewart
Assistant Professor of Clinical Obstetrics & Gynecology
Indiana University